Evidence map›Paper›PMID 25015835›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.

Allison Sang, Haitao Niu, Jaime Cullen, Seung Chul Choi, Ying Yi Zheng, Haowei Wang, Mark J Shlomchik, Laurence Morel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. B Cell Receptor Repertoire Analysis of the CD21European journal of immunology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Allison SangDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
Haitao NiuDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
Jaime CullenDepartment of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520; and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Seung Chul ChoiDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
Ying Yi ZhengDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
Haowei WangDepartment of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520; and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Mark J ShlomchikDepartment of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06520; and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.
Laurence MorelDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610; morel@ufl.edu.
University of Florida · USYale University · US

Funding

Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
B Cell Development Defects in Murine LupusR01AI058150 · NIAID · UNIVERSITY OF FLORIDA · PI MOREL, LAURENCE · 2004 to 2014
$3.7M
Activation and regulation of autoreactive B cells in health and diseaseR01AI073722 · NIAID · YALE UNIVERSITY · PI SHLOMCHIK, MARK J · 2008 to 2012
$2.6M
Mechanisms of B-Cell Tolerance in a Mouse Model of LupusF31AI094925 · NIAID · UNIVERSITY OF FLORIDA · PI SANG, ALLISON · 2012 to 2013
$69k
NIAID NIH HHS F31 AI094925NIAID NIH HHS R01 AI058150NIAID NIH HHS R01 AI073722NIAID NIH HHS T32 AI074491PHS HHS R01 A058150
6 · The paper itself

Abstract

AM14 rheumatoid factor (RF) B cells in the MRL/lpr mice are activated by dual BCR and TLR7/9 ligation and differentiate into plasmablasts via an extrafollicular (EF) route. It was not known whether this mechanism of activation of RF B cells applied to other lupus-prone mouse models. We investigated the mechanisms by which RF B cells break tolerance in the NZM2410-derived B6.Sle1.Sle2.Sle3 (TC) strain in comparison with C57BL/6 (B6) controls, each expressing the AM14 H chain transgene in the presence or absence of the IgG2a(a) autoantigen. The TC, but not B6, genetic background promotes the differentiation of RF B cells into Ab-forming cells (AFCs) in the presence of the autoantigen. Activated RF B cells preferentially differentiated into plasmablasts in EF zones. Contrary to the MRL/lpr strain, TC RF B cells were also located within germinal centers, but only the formation of EF foci was positively correlated with the production of RF AFCs. Immunization of young TC.AM14 H chain transgenic mice with IgG2a(a) anti-chromatin immune complexes (ICs) activated RF B cells in a BCR- and TLR9-dependent manner. However, these IC immunizations did not result in the production of RF AFCs. These results show that RF B cells break tolerance with the same general mechanisms in the TC and the MRL/lpr lupus-prone genetic backgrounds, namely the dual activation of the BCR and TLR9 pathways. There are also distinct differences, such as the presence of RF B cells in GCs and the requirement of chronic IgG2a(a) anti-chromatin ICs for full differentiation of RF AFCs.

Indexed as

AnimalsAutoantibodiesAutoantigensB-LymphocytesCell DifferentiationCells, CulturedChromatinDisease Models, AnimalFemaleGerminal CenterImmune ToleranceImmunoglobulin GLupus Erythematosus, SystemicLymphocyte ActivationMiceMice, Inbred BALB CAutoantibodiesAutoantigensChromatinImmunoglobulin GReceptors, Antigen, B-CellRheumatoid FactorTLR7 protein, humanTLR9 protein, humanToll-Like Receptor 7Toll-Like Receptor 9

Identifiers

PMID25015835
PMCPMC4119566
OpenAlexW2111231915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.